- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Life Technologies Corp
Add to PortfolioLIFE:US
41.8100 USD 0.0200 0.05%As of 20:10:00 ET on 05/29/2012.
Snapshot for Life Technologies Corp (LIFE)
| Open: | 41.9900 | Day's Range: | 41.6400 - 42.3700 | Volume: | 1,265,242 | Bid: | 41.8000 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 41.8300 | 52wk Range: | 35.3000 - 53.2700 | 1-Yr Rtn: | -19.44% | Ask: | 41.8100 |
Key Statistics for LIFE
| Current P/E Ratio (ttm) | 15.3150 |
|---|---|
| Estimated P/E (12/2012) | 10.3927 |
| Earnings Per Share (USD) (ttm) | 2.7300 |
| Est. EPS (USD) (12/2012) | 4.0230 |
| Est. PEG Ratio | 1.2238 |
| Market Cap (M USD) | 7,466.29 |
| Shares Outstanding (M) | 178.58 |
| Enterprise Value (M USD) (ttm) | 9,643.69 |
| Enterprise Value/EBITDA (ttm) | 7.71 |
| Price/Book (mrq) | 1.5838 |
| Price/Sale (ttm) | 1.9597 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/27/2012 |
More LIFE Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for LIFE
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for LIFE
Life Technologies Corporation develops biotechnology tools used by researchers. The Company offers a broad range of products and services, including systems, instruments, reagents, and custom services. Life's portfolio of products includes technologies for capillary electrophoresis based sequencing, sequencing, mass spectrometry sample preparation, and cell culture.
| Gregory T LucierChairman/CEO | Mark P StevensonPresident/COO |
| John A CottinghamChief Legal Officer/Secy | Ronald A Andrews Jr "Ronnie"President:Medical Sciences |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page